BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36582341)

  • 1. The moderating effect of psychological trust on knowledge spillovers and firms' open innovation.
    Huang R; Jin J; Sunguo T; Liu Y
    Front Psychol; 2022; 13():1071625. PubMed ID: 36582341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance: Moderating roles of scientific collaboration strength and patent stock.
    Wang XX; Jiao HY
    Front Public Health; 2022; 10():980845. PubMed ID: 36033805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of University agricultural research and development spillovers on Chinese agribusiness firms' performance.
    Wang Y; Yu D
    PLoS One; 2023; 18(12):e0296007. PubMed ID: 38100486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management or technology? Firms' embeddedness in dual talent flow networks and their innovation performance.
    Sun B; Ruan A; Peng B; Liu S
    Front Psychol; 2022; 13():1028818. PubMed ID: 36425841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous knowledge spillover channels in universities and green technology innovation in local firms: Stimulating quantity or quality?
    Nie L; Gong H; Zhao D; Lai X; Chang M
    Front Psychol; 2022; 13():943655. PubMed ID: 36300040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cooperation stimulate firms' eco-innovation? Firm-level evidence from China.
    Zhang S; Xu X; Wang F; Zhang J
    Environ Sci Pollut Res Int; 2022 Nov; 29(51):78052-78068. PubMed ID: 35689768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Cooperative Innovation on the Technological Innovation Performance of High-Tech Firms: A Dual Moderating Effect Model of Big Data Capabilities and Policy Support.
    Li X; Wang Q; Shi R; Wang X; Zhang K; Liu X
    Big Data; 2024 Feb; 12(1):63-80. PubMed ID: 37707986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of analyst attention on the firms' innovation paths from a life cycle perspective: Evidence from China.
    Yao J; Wang D
    Heliyon; 2023 Aug; 9(8):e18940. PubMed ID: 37636392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental regulation and green innovation of polluting firms in China.
    He L; Wang M
    PLoS One; 2023; 18(3):e0281303. PubMed ID: 36893093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEOs' psychological trait and firms' adoption of blockchain technology: The role of hometown identity.
    Wang L; Xiao W; Xie S; Wei R
    Front Psychol; 2022; 13():1005249. PubMed ID: 36467173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting firms' green technology innovation: an evolutionary game based on prospect theory.
    Li C; Wang Z; Wang L
    Environ Monit Assess; 2022 Dec; 195(1):227. PubMed ID: 36565338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discretionary Effort on Green Technology Innovation: How Chinese Enterprises Act when Facing Financing Constraints.
    Zhang K; Liu X; Hong M
    PLoS One; 2021; 16(12):e0261589. PubMed ID: 34936690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does green innovation facilitate firms' access to trade credit?
    Liu Q; Tang J
    Environ Sci Pollut Res Int; 2023 Dec; 30(57):120683-120706. PubMed ID: 37945952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
    Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
    PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divisive Faultlines and Knowledge Search in Technological Innovation Network: An Empirical Study of Global Biopharmaceutical Firms.
    Cheng L; Wang M; Lou X; Chen Z; Yang Y
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34074011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological capital and breakthrough innovation: The role of tacit knowledge sharing and task interdependence.
    Hu R; Li Y; Huang J; Zhang Y; Jiang R; Dunlop E
    Front Psychol; 2023; 14():1097936. PubMed ID: 36874849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The U-shaped impact of export quality on firms' innovation output: Empirical evidence from China.
    Cai Y; Wu G
    PLoS One; 2024; 19(2):e0298358. PubMed ID: 38394251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Would consumers pay for environmental innovation? The moderating role of corporate environmental violations.
    Long S; Liao Z
    Environ Sci Pollut Res Int; 2021 Jun; 28(23):29075-29084. PubMed ID: 33550549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental regulation, firms' bargaining power, and firms' total factor productivity: evidence from China.
    Yang S; Wang C; Zhang H; Lu T; Yi Y
    Environ Sci Pollut Res Int; 2022 Feb; 29(6):9341-9353. PubMed ID: 34499302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foreign executives, digital transformation, and innovation performance: Evidence from Chinese-listed firms.
    Shao D; Lv K; Fan X; Zhang B
    PLoS One; 2024; 19(6):e0305144. PubMed ID: 38848381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.